Stock News
Exro Technologies Shatters Records with Q2 Financial Results: A Game-Changing Milestone for the Future of Energy
Exro Technologies Inc. Reports Record Quarter Financial Results Exceed Expectations Exro Technologies Inc., a leading clean-technology company, has announced its financial results for the second quarter ended June 30, 2024. The company reported a record quarterly revenue of C$5.3 million, with total revenue reaching C$6.7 million by the end of the quarter. This exceeded targeted…
Unveiling the Future: A Recap of Cineverse Corp’s Q1 2025 Earnings Call
Cineverse Corp. (NASDAQ:CNVS) Q1 2025 Earnings Conference Call August 14, 2024 4:30 PM ET Company Participants: Gary Loffredo – Chief Legal Officer, Secretary and Senior Advisor Chris McGurk – Chairman and Chief Executive Officer Mark Lindsey – Chief Financial Officer Erick Opeka – President and Chief Strategy Officer Conference Call Participants: Brian Kinstlinger – Alliance…
Reflecting on Progress: Aileron Therapeutics’ Second Quarter 2024 Financial Results and Business Highlights
Positive Data from Phase 1b Clinical Trial of LTI-03 A Promising Development in the Treatment of Idiopathic Pulmonary Fibrosis Today, Aileron Therapeutics, Inc. announced positive data from Cohort 1 of the ongoing Phase 1b clinical trial of LTI-03, a potential breakthrough in the treatment of idiopathic pulmonary fibrosis (IPF). The trial evaluated low-dose LTI-03 (2.5…
Vuzix Corporation’s Q2 2024 Earnings Call: A Comprehensive Recap
Welcome to the Vuzix Q2 2024 Earnings Conference Call Company Participants Ed McGregor – Director, Investor Relations Paul Travers – Chief Executive Officer Grant Russell – Chief Financial Officer Conference Call Participants Matt VanVliet – BTIG Tyler Burmeister – Craig-Hallum Capital Group Greetings, and welcome to the Vuzix Second Quarter for the Period Ending June…
Plus Therapeutics: A Look at Our Second Quarter 2024 Financial Results and Exciting Business Updates!
Positive Interim ReSPECT-LM Phase 1 Data for Rhenium (186 Re) Obisbemeda for Leptomeningeal Metastases Presented Positive Topline Clinical Trial Results for CNSide diagnostic in the FORESEE trial Management to host conference call August 14, 2024 at 5:00 p.m. ET AUSTIN, Texas, Aug. 14, 2024 (GLOBE NEWSWIRE) — Plus Therapeutics, Inc. (Nasdaq: PSTV), a clinical-stage pharmaceutical…
Unlocking the Power of Emotion: A Heartfelt and Insightful Journey
Unlocking the Power of Emotion: A Heartfelt and Insightful Journey FAIRFAX, VA / ACCESSWIRE / August 14, 2024 / WidePoint Corporation (NYSE American: WYY ) Second Quarter 2024 and Recent Operational Highlights: Awarded $254 million contract modification by the U.S. Department of Homeland Security increasing the ceiling of the Cellular Wireless Management Services 2.0 contract…
Discover the Power of Emotional Connection: A Heartfelt and Insightful Blog Post
Exciting News for Rekor Systems, Inc. Financial Success and Growth Strengthening Financial Position Rekor Systems, Inc. recently announced that they have received a $15 million prepaid advance under a facility that provides up to $35 million in financing. This move has significantly strengthened the company’s financial position, allowing for future growth initiatives and expansion. Impressive…
Unleash Your Power: Join the Fight Against Securities Fraud with the Schall Law Firm and Lead the Way for DXC Investors!
Unleash Your Power: Join the Fight Against Securities Fraud with the Schall Law Firm and Lead the Way for DXC Investors! LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) — The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against DXC Technology Company (“DXC” or “the Company”)…